FORTE Study News: It’s Colorectal Cancer Awareness Month!

March 15 2023

NRG-CC005/FORTE team has created graphics and captions for distribution across social media platforms – Facebook, Instagram, Twitter, and LinkedIn – for site research staff to use when corresponding, presenting, and following up with participants, patients, and the general public for the NRG-CC005/FORTE study. The graphics include:  

  • General information on colorectal cancer  
  • General information on clinical trials  
  • FORTE Study information  
  • Graphics for each state that currently has NRG-CC005 sites activated 
These participant-directed materials have been reviewed and approved by the NCI CIRB. The “Colorectal Cancer Awareness Month” document, along with the CIRB approval letter, are found under the CIRB tab on the CTSU website for NRG-CC005. Before distribution, sites must submit to their local IRB if required per site/local policy. Collaborate with your site communications teams and departments to distribute information on the FORTE study throughout Colorectal Cancer Awareness Month (March 2023).  

Use hashtags about #ColorectalCancerAwarenessMonth to promote #FORTEStudy throughout March!  

#clinicaltrial #clinicaltrials #clinicalresearch #cancerprevention #cancer #cancerawareness #cancerresearch #coloncancer #colorectalcancer #ColonCancerAwareness #colorectalcancerawarenessmonth #coloncancerprevention #colorectalcancerawareness #colorectalcancerscreening #oncology #Gastroenterology #BlueForCRC  


Accrual Updates and Milestones (as of February 28, 2023)  
Top accruing sites: 
  • Kaiser Permanente – Vallejo – 214 accrued  
  • UPMC-Presbyterian Hospital – 77 accrued 
  • Park Nicollet Clinic - Saint Louis Park – 58 accrued  
Most recent randomizations:  
  • Kaiser Permanente-Vallejo – February 28, 2023 
  • Zablocki Veterans Administration Medical Center – February 27, 2023  
  • Maine Medical Center- Scarborough Campus – February 27, 2023  
  • Essentia Health Cancer Center – February 23, 2023  
  • Regions Hospital – February 23, 2023 
Thanks to your recruitment efforts, FORTE has accrued over 400 participants! 14 activated sites accrued participants since the beginning of 2023. Keep up the good work! 

Questions from Site Research Staff 
If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at:  
1(800) 477-7227  

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.